Published on June 29, 2011
Discovery could lead to earlier detection and personalized cancer treatment
FOR IMMEDIATE RELEASE:
June 29, 2011
MEDIA CONTACT:
Eileen Sexton
(703) 837-3691
eileen.sexton@preventcancer.org
(Alexandria, Va.)—The Prevent Cancer Foundation applauds the latest findings in the July issue of Cancer Discovery, an American Association for Cancer Research journal, reporting that a collaboration of scientists has now identified the actual sequence of mutations that lead to precancerous lesions and others that produce invasive carcinomas. The study, “Temporal Dissection of Tumorigenesis in Primary Cancers,” represents a critical step in personalizing cancer treatment and earlier diagnosis.
The Foundation is encouraged by the discovery and believes that these scientific findings could potentially lead to greater understanding of cancer prevention and early detection. “Understanding genetic malfunctions is a critical step and could lead to great advances in personalizing cancer treatment,” said Carolyn Aldige, President and Founder, Prevent Cancer Foundation, www.preventcancer.org. “It could also mean that many more cases of cancer are diagnosed at earlier stages, when the chance of a successful treatment outcome is markedly higher.”
# # #
About The Prevent Cancer Foundation:
The mission of the Prevent Cancer Foundation is to save lives through cancer prevention and early detection. Founded in 1985, the Foundation has provided more than $125 million in support of cancer prevention and early detection research, education, advocacy and community outreach nationwide. For more information, please visit www.preventcancer.org.
